MedTrace Logo

Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™

NCT03247829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2024-04-26

Study results available
· View outcomes & findings →

Summary

This observational post market study is intended to characterize hemodynamic-guided management of patients with an existing left ventricular assist device (LVAD) to protocol specified target ranges and its impact on functional status, quality of life, and readmissions

Conditions

Interventions

DEVICE

Hemodynamic management using CardioMEMS HF System

Using the CardioMEMS HF System, clinicians will treat to target PA pressure ranges

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Kartik Sundareswaran · Abbott

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-24
Primary Completion
2020-03-06
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03247829 on ClinicalTrials.gov